Climb Bio, Inc.

CLYM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001768446

SEC filings (opens in a new tab)

In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Climb Bio, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of CLYM: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	80	1	108	+29
Shares	32.3M	18	56.3M	+24.0M (+74.5%)
Value	$221.2M	$123	$734.3M	+$513.2M (+232.0%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (51)

Institutions that held Climb Bio, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CLYM in Q2 2026
Institution	Shares	Value	% of portfolio
Adage Capital Partners GP, L.L.C.	2,506,000	$32.7M	0.05%
Cormorant Asset Management, LP	2,106,000	$27.5M	1.41%
Frontier Capital Management Co LLC	1,939,019	$25.3M	0.24%
Woodline Partners LP	1,582,291	$20.6M	0.06%
Redmile Group, LLC	1,226,330	$16.0M	1.07%
StemPoint Capital LP	742,745	$9.69M	1.68%
Ameriprise Financial Inc	657,971	$8.58M	0.00%
Parkman Healthcare Partners LLC	563,484	$7.35M	0.75%
Invesco Ltd.	373,445	$4.87M	0.00%
Ikarian Capital, LLC	300,000	$3.91M	0.64%
Ally Bridge Group (NY) LLC	249,172	$3.25M	4.19%
Vanguard Portfolio Management LLC	239,657	$3.13M	0.00%
Fifth Third Bancorp	164,923	$2.15M	0.00%
Schonfeld Strategic Advisors LLC	126,138	$1.64M	0.01%
Bank of New York Mellon Corp	123,658	$1.61M	0.00%
Wellington Management Group LLP	96,807	$1.26M	0.00%
Nuveen, LLC	85,935	$1.12M	0.00%
Cambria Investment Management, L.P.	76,109	$992.5K	0.05%
EAM Investors, LLC	69,657	$908.3K	0.08%
DeepCurrents Investment Group LLC	64,286	$838.3K	0.03%
Alps Advisors Inc	58,121	$757.9K	0.00%
SEI Investments Co	49,456	$644.9K	0.00%
American Century Companies Inc	47,250	$616.1K	0.00%
Rhumbline Advisers	44,544	$580.8K	0.00%
Oppenheimer & Co Inc	41,498	$541.1K	0.01%
Integrated Quantitative Investments LLC	31,406	$409.5K	0.07%
Wells Fargo & Company	30,660	$399.8K	0.00%
D. E. Shaw & Co., Inc.	28,800	$375.6K	0.00%
Virtus Investment Advisers, Inc.	28,602	$373.0K	0.09%
Franklin Resources Inc	24,639	$321.3K	0.00%
MetLife Investment Management	21,305	$277.8K	0.00%
Alliancebernstein L.P.	31,670	$216.9K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	16,153	$210.6K	0.00%
STRS Ohio	15,300	$199.5K	0.00%
State of Wyoming	14,374	$187.4K	0.02%
Spark Investment Management LLC	13,600	$177.3K	0.35%
New York State Common Retirement Fund	12,300	$160.4K	0.00%
Virtu Financial LLC	11,151	$145.0K	0.00%
Bailard, Inc.	10,900	$142.1K	0.00%
SummitTX Capital, L.P.	10,791	$140.7K	0.00%
Police & Firemen's Retirement System of New Jersey	10,390	$135.5K	0.00%
Acadian Asset Management LLC	4,533	$59.0K	0.00%
Legal & General Group Plc	3,419	$44.6K	0.00%
Ameritas Investment Partners, Inc.	3,197	$41.7K	0.00%
US Bancorp	3,120	$40.7K	0.00%
Caitong International Asset Management Co., Ltd	886	$11.6K	0.00%
Farther Finance Advisors, LLC	821	$10.7K	0.00%
California State Teachers Retirement System	485	$6.32K	0.00%
Sterling Capital Management LLC	452	$5.89K	0.00%
Simplex Trading, LLC	74	$964	0.00%
EverSource Wealth Advisors, LLC	47	$613	0.00%

Sold out (22)

Institutions that held Climb Bio, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CLYM in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
MPM Oncology Impact Management LP	2,593,439	$17.8M
Kynam Capital Management, LP	1,003,341	$6.87M
Marshall Wace, LLP	773,123	$5.30M
Silverarc Capital Management, LLC	684,908	$4.69M
Diadema Partners LP	286,126	$1.96M
Longaeva Partners L.P.	217,768	$1.49M
Seven Fleet Capital Management LP	130,654	$895.0K
Peapod Lane Capital LLC	108,878	$739.8K
683 Capital Management, LLC	90,000	$616.5K
Persistent Asset Partners Ltd	72,325	$495.4K
Point72 Asset Management, L.P.	59,090	$404.8K
Brevan Howard Capital Management LP	56,624	$387.9K
Hudson Bay Capital Management LP	54,460	$373.1K
HRT Financial LP	37,161	$254.0K
Cantor Fitzgerald, L. P.	30,000	$205.5K
Fox Run Management, L.L.C.	19,287	$126.1K
Omers Administration Corp	16,700	$114.4K
Diametric Capital, LP	11,218	$76.8K
JustInvest LLC	11,204	$76.7K
Balyasny Asset Management LLC	6,959	$47.7K
Advisory Services Network, LLC	2,032	$13.9K
SRS Capital Advisors, Inc.	51	$110

Not filed for Q2 2026 yet (1)

Institutions that held Climb Bio, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLYM in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	18	$123